47° Sunny

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition
STOCKING STUFFER CONTEST

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Biogen Idec (NQ:BIIB)

169.38 -2.72 (-1.58%)

Streaming Delayed Price Updated: 2:33 PM EST, Dec 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biogen Idec

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

56 57 Next >

Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So ↗

April 18, 2023

On their own, cancer or diabetes can be debilitating and deadly. The two are common diseases with tremendous impact on health worldwide.

Via Benzinga

Leqembi Sales To Propel Biogen Stock To New Heights, Says Bullish Analyst ↗

April 17, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023 ↗

April 17, 2023

Via Benzinga

Biogen Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗

April 17, 2023

Via Benzinga

12 Analysts Have This to Say About Biogen ↗

April 11, 2023

Via Benzinga

A Look Into Biogen's Debt ↗

April 03, 2023

Via Benzinga

3 Stocks to Buy That Could Be the Next Biotech Breakthrough ↗

April 16, 2023

Biotech stocks are highly speculative, but it's possible to choose ones with excellent risk-reward ratios.

Via InvestorPlace

7 Sorry Pharma Stocks to Sell in April Before It’s Too Late ↗

April 16, 2023

You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards.

Via InvestorPlace

Biogen Moves Deeper In Alzheimer's With Denali ↗

April 14, 2023

Biogen exercised their rights to a Denali Alzheimer's drug. What does this mean longer term to the field and the companies?

Via Talk Markets

The Unexpected Way The Texas Abortion Ruling Could Destroy Biotech ↗

April 14, 2023

One executive called this the most "damaging" decision in five decades.

Via Investor's Business Daily

New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications ↗

April 12, 2023

New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this...

Via Benzinga

Price Over Earnings Overview: Biogen ↗

March 31, 2023

Via Benzinga

Biogen Unusual Options Activity ↗

March 23, 2023

Via Benzinga

11 Analysts Have This to Say About Biogen ↗

March 23, 2023

Via Benzinga

Biogen Exercises Option with Denali to Develop and Commercialize Antibody Transport Vehicle Program Targeting Amyloid Beta

April 12, 2023

Program uses Denali’s Antibody Transport Vehicle (ATV) technology to cross the blood-brain barrier (BBB) and aims to increase target engagement

From Denali Therapeutics Inc.

Via GlobeNewswire

Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead ↗

April 11, 2023

In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating...

Via Benzinga

3 Biotech Stocks to Watch for Potential Breakthroughs ↗

April 11, 2023

These biotech stocks have significant upside and realistic breakthrough chances in the current and distant future.

Via InvestorPlace

Twitter Inc Is Officially Defunct, Alibaba Plans to Integrate ChatGPT Like Chatbot Across Products, Moderna's Flu Shot Study Misses 'Early Success' Criteria: Today's Top Stories ↗

April 11, 2023

Benzinga Twitter Inc Is Officially Defunct As Elon Musk Pursues' Superapp' Goal

Via Benzinga

Drugmakers Stand Up for Reproductive Rights: Pfizer and Biogen Among 300 Condemning Abortion Pill Approval Suspension ↗

April 11, 2023

Via Benzinga

Top-Notch Biotech TG Therapeutics Logs 'Solid Jump' In Sales; Shares Rocket ↗

April 10, 2023

Shares are closing in on a buy point out of a consolidation.

Via Investor's Business Daily

The 3 Best Millionaire-Maker Stocks to Buy for April 2023 ↗

April 07, 2023

These millionaire-maker stocks certainly have the growth profiles to help investors reach their goals of becoming a millionaire.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

April 07, 2023

Via Benzinga

Biogen Appoints Adam Keeney as Head of Corporate Development

April 04, 2023

From Biogen Inc.

Via GlobeNewswire

Tesla Manufactured 4,000 Model Ys In One Week, UBS Prepping For Massive Layoffs, McDonald's Temporary Shuttering Of US Offices: Today's Top Stories ↗

April 03, 2023

Bloomberg UBS Prepping For Massive Layoffs Amid Credit Suisse Takeover

Via Benzinga

National Institute on Aging Aims Building $300M Alzheimer's Research Database ↗

April 03, 2023

The U.S. National Institute on Aging (NIA), part of the government's National Institutes of Health (NIH), aims to build an Alzheimer's research database. Alzheimer's Association Chief Science Officer...

Via Benzinga

Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug ↗

March 31, 2023

Via Benzinga

Additional Detailed Analyses From Phase 2 Study 201 of Lecanemab Published as Three Papers in Peer-Reviewed Journals

March 30, 2023

From Biogen Inc.

Via GlobeNewswire

Eisai Presented New Analyses of ARIA and QOL on Lecanemab in Clarity AD at the AD/PD™ 2023 Annual Meeting

March 30, 2023

From Biogen Inc.

Via GlobeNewswire

New Data Presented at AD/PD™ 2023 Show Biogen’s BIIB080 (MAPT ASO) Substantially Reduced Tau Protein Levels in Patients with Early-stage Alzheimer’s Disease

March 29, 2023

From Biogen Inc.

Via GlobeNewswire

7 Blue-Chip Stocks Sitting in the Sweet Spot ↗

March 23, 2023

Although blue-chip stocks carry a reputation for being bulky and not exciting, these large enterprises can really move.

Via InvestorPlace

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

56 57 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Biogen Idec (NQ:BIIB)

All News about Biogen Idec

Sections

Services